Sign in

CIK 0001297184 · Large accelerated filer

Amphastar Pharmaceuticals, Inc.

Sign in to watch
Ticker
AMPH
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
operating
EIN
330702205
Phone
909-980-9484
Business address
11570 SIXTH STREET, RANCHO CUCAMONGA, CA, 91730
  1. 4 Open-market sale Director sold 8,000 shares at $20.06 ($160,501)
  2. 8-K Event Material agreement · Other events
  3. 10-Q Report Quarterly Report
  4. 8-K Event Results of operations
  5. 4 Open-market sale Director sold 400 shares at $18.09 ($7,236)
  6. UPLOAD Other SEC-generated Letter
  7. CORRESP Other Correspondence Between Filers and SEC Staff
  8. 4 Open-market sale Director sold 400 shares at $18.75 ($7,500)
  9. 4 Open-market sale President and General Counsel sold 56,996 shares at $19.50 ($1,111,268)
  10. UPLOAD Other SEC-generated Letter
  11. 4 Open-market sale CEO & Chief Science Officer sold 444,199 shares at an average $21.03 ($9,342,804)
  12. 4 Open-market sale Director sold 3,000 shares at $19.05 ($57,150)
  13. 4 Open-market sale Director sold 10,381 shares at $18.78 ($194,917)
  14. 4 Open-market sale President and General Counsel sold 10,000 shares at $19.95 ($199,500)
  15. 4 Open-market sale Director sold 3,086 shares at $19.62 ($60,539)
  16. 4 Open-market sale EVP, QA & Regulatory Affairs sold 24,046 shares at $19.28 ($463,607)
  17. 4 Open-market sale President and General Counsel sold 5,987 shares at $18.86 ($112,909)
  18. 4 Open-market sale Director sold 48,375 shares at an average $18.24 ($882,281)
  19. 4 Open-market sale Director sold 48,375 shares at an average $18.15 ($878,106)
  20. 4 Open-market sale CFO, SVP & Treasurer sold 1,027 shares at $18.19 ($18,681)

Page 39 of 48 · 958 filings